Skip to main content

Metformin

Also known as: Glucophage

Classification

Pharmaceutical

Regulatory Status

FDA-approved

Sources

1

Review

n/a

Overview

Metformin is represented by its commonly described biguanide insulin sensitizer mechanism. This conservative launch record supports search and overlap detection, not medical recommendation.

Evidence and limitations

Human/preclinical evidence breakdown is not available in this record.

Pathways

AMPK-signalingglucose-regulationbiguanide insulin sensitizerinsulin-sensitivity

Benefits

People look up metformin as a first-line biguanide prescription for type 2 diabetes to improve glycemic control. Labeled use is educational reference only, not a personal recommendation.

Interactions & cautions

iodinated contrast procedures without clinical review

alcohol — Potential additive or opposing effects may occur. (review)

These are observational flags for review, not individualized instructions.

Sources

Educational reference only — not medical advice.

What people report (anecdote)

CLINICAL DATA (from trials)

Adverse events:

None recorded in our sources.

Effects measured:

Human trials: none found.

ANECDOTE

What people report: anecdote, not evidence

Loading…

Submit a claim you saw
Metformin: what the evidence actually says | BioStack